Patents by Inventor Matthew Spitzer

Matthew Spitzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of identifying and treating patient populations amenable to cancer immunotherapy
    Patent number: 11699503
    Abstract: Methods for identifying cancer patients amenable to anti-cancer immunotherapy are provided along with methods of monitoring cancer therapy. Also provided are methods of treating cancer patients amenable to anti-cancer immunotherapy. The methods involve determining the level of CD127 <low> PD-1 <low> T cells. The patients are treated with an immune checkpoint inhibitor, such as an anti-CTLA-4 antibody, e.g. ipilimumab.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: July 11, 2023
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Matthew Spitzer, Lawrence Fong
  • Methods of Identifying and Treating Patient Populations Amenable to Cancer Immunotherapy
    Publication number: 20190378594
    Abstract: Methods for identifying cancer patients amenable to anti-cancer immunotherapy are provided along with methods of monitoring cancer therapy. Also provided are methods of treating cancer patients amenable to anti-cancer immunotherapy. The methods involve determining the level of CD127<low>PD-1<low>T cells. The patients are treated with an immune checkpoint inhibitor, such as an anti-CTLA-4 antibody, e.g. ipilimumab.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 12, 2019
    Inventors: Matthew Spitzer, Lawrence Fong